Literature DB >> 10806841

The role for endothelin in mesangial proliferative glomerulonephritis.

H Wu1, H Wang, Y Wang, T Liu, Y Kuang.   

Abstract

To understand the effect of endothelin (ET) on the mesangium and matrix proliferation on the basis of hyperlipidemia, the model of mesangial proliferative glomerulonephritis (MSPGN) was established by intravenously giving calf serum albumin (250 mg/L) to the rabbits fed on feed containing 1% cholesterol for 4-8 weeks. Our results showed that in the 4th week of the experiment, the ET level in experiment group was significantly higher than that of normal controls (P < 0.01) and the pathological examination revealed development of MSPGN. In the 8th week of the experiment, the ET level was further elevated and pathological study demonstrated local glomerular sclerosis and infiltration of lymphocytes of interstitia. We are led to conclude that ET, as a newly identified hormone, is involved in the pathogenesis and development of MSPGN and acts as an important regulator in the proliferation of mesangium and accumulation of matrix of basal membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10806841     DOI: 10.1007/bf02888483

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  2 in total

1.  Endothelin peptides: a possible role in glomerular inflammation.

Authors:  M S Simonson; M J Dunn
Journal:  Lab Invest       Date:  1991-01       Impact factor: 5.662

2.  Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways.

Authors:  K F Badr; J J Murray; M D Breyer; K Takahashi; T Inagami; R C Harris
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

  2 in total
  1 in total

1.  C3G overexpression in glomerular epithelial cells during anti-GBM-induced glomerulonephritis.

Authors:  Victoriya A Rufanova; Elias Lianos; Anna Alexanian; Elena Sorokina; Mukut Sharma; Ann McGinty; Andrey Sorokin
Journal:  Kidney Int       Date:  2008-09-10       Impact factor: 10.612

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.